3SBio (TRSBF) Expected to Announce Earnings on Monday

3SBio (OTCMKTS:TRSBF) is projected to issue its results before the market opens on Monday, March 30th. Analysts expect the company to announce earnings of $0.5160 per share and revenue of $1.9761 billion for the quarter.

3SBio Price Performance

Shares of OTCMKTS TRSBF opened at $2.58 on Monday. 3SBio has a twelve month low of $2.22 and a twelve month high of $4.74. The firm has a 50-day moving average of $2.89 and a two-hundred day moving average of $3.42.

About 3SBio

3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.

The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.